Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

by Merry, Eve , Soosaipillai, Gehan , Shaw, Heather , Sng, Christopher C. T. , Ottaviani, Diego , Chowdhury, Amani , Sinclair, Alasdair , Patel, Grisma , Roylance, Rebecca , Earnshaw, Irina , Chopra, Neha , Wong, Yien Ning Sophia , Galazi, Myria , Wu, Anjui , Benafif, Sarah , Lee, Alvin J. X.

in Cancer / Cancer therapies / Chemotherapy / Coronaviruses / COVID-19 / COVID-19 vaccines / Cytotoxicity / Data collection / Death / Demography / Ethics / FDA approval / Hospitals / Immunization / Immunosuppression / Immunotherapy / Infections / Laboratories / Metastases / Morbidity / Mortality / Pandemics / Patients / Risk factors / Severe acute respiratory syndrome coronavirus 2 / University colleges

2021

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

2021

Confirm

Do you wish to request the book?

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

2021

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

Merry, Eve,

Soosaipillai, Gehan,

Shaw, Heather,

Sng, Christopher C. T.,

Ottaviani, Diego,

Chowdhury, Amani,

Sinclair, Alasdair,

Patel, Grisma,

Roylance, Rebecca,

Earnshaw, Irina,

Chopra, Neha,

Wong, Yien Ning Sophia,

Galazi, Myria,

Wu, Anjui,

Benafif, Sarah,

Lee, Alvin J. X.

2021

Overview

An increased mortality risk was observed in patients with cancer during the first wave of COVID-19. Here, we describe determinants of mortality in patients with solid cancer comparing the first and second waves of COVID-19. A retrospective analysis encompassing two waves of COVID-19 (March–May 2020; December 2020–February 2021) was performed. 207 patients with cancer were matched to 452 patients without cancer. Patient demographics and oncological variables such as cancer subtype, staging and anti-cancer treatment were evaluated for association with COVID-19 mortality. Overall mortality was lower in wave two compared to wave one, HR 0.41 (95% CI: 0.30–0.56). In patients with cancer, mortality was 43.6% in wave one and 15.9% in wave two. In hospitalized patients, after adjusting for age, ethnicity and co-morbidities, a history of cancer was associated with increased mortality in wave one but not wave two. In summary, the second UK wave of COVID-19 is associated with lower mortality in hospitalized patients. A history of solid cancer was not associated with increased mortality despite the dominance of the more transmissible B.1.1.7 SARS-CoV-2 variant. In both waves, metastatic disease and systemic anti-cancer treatment appeared to be independent risk factors for death within the combined cancer cohort.

Share this book

Add to My Shelf

Publisher

MDPI AG,MDPI

Subject